[ACRX] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
07-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -0.80%
YoY- -27.04%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 608 941 265 613 377 818 343 46.41%
PBT -12,731 -12,409 -13,674 -12,558 -12,458 -10,539 -11,592 6.44%
Tax 1,212 3 627 355 -2,601 2 136 329.27%
NP -12,731 -12,412 -13,674 -12,558 -12,458 -10,541 -11,592 6.44%
Tax Rate - - - - - - - -
Total Cost 13,339 13,353 13,939 13,171 12,835 11,359 11,935 7.68%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -2,093.91 -1,319.02 -5,160.00 -2,048.61 -3,304.51 -1,288.63 -3,379.59 -27.30%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -3.20 -3.15 -3.47 -3.56 -4.15 -4.07 -4.55 -20.89%
EPS Diluted -3.20 -3.15 -3.47 -3.56 -4.15 -4.07 -4.55 -20.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.